Seller record · Telehealth service

Joi and Blokes

By Peptide Alliance, Editorial publisherRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S4, compounding disclosure: The site sells compounded GLP-1 treatments, and its home, about, contact and terms pages never state that they lack Food and Drug Administration approval. 1 more criterion also fails; see the table below.

At a glance

Joi and BlokesTelehealth service

5/8criteria passed

Price: Printed on its own pages before sign-up
Sells: compounded GLP-1 treatments, compounded GLP-1 and GIP treatments, and 2 more
FDA letters: 1 on file

Visit Joi and Blokes See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.

A hormone and metabolic telehealth service selling compounded GLP-1 and GLP-1 with GIP treatments to men and women. Its terms name the pharmacy that fills its orders and the number of locations that pharmacy operates.

Operating entity No legal entity name is printed in the footer, the about page, the contact page or the terms.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Joi and Blokes' website
S2	Prescription gating	NOT VERIFIED	Joi and Blokes' schedule page
S3	Pharmacy identification	PASS	Joi and Blokes' terms
S4	Compounding disclosure	FAIL	Joi and Blokes' about page
S5	Analytical documentation	FAIL	Joi and Blokes' terms
S6	Business address	PASS	Joi and Blokes' contact page
S7	Price disclosure	PASS	Joi and Blokes' about page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSEvery prescription requires a medical consultation with a licensed provider who decides whether to prescribe, and the site names no individual prescriber.Source: Joi and Blokes' website.

S2NOT VERIFIEDThe medical intake did not resolve, because the scheduling page presents a checkout and login form and an accessibility overlay, and no health question loaded. The check is open.Source: Joi and Blokes' schedule page.

S3PASSThe terms name Strive Pharmacy as the filling pharmacy and state that it owns and operates six pharmacy locations in the United States.Source: Joi and Blokes' terms.

S4FAILThe site sells compounded GLP-1 treatments, and its home, about, contact and terms pages never state that they lack Food and Drug Administration approval.Source: Joi and Blokes' about page.

S5FAILNo certificate, lot number or purity figure appears anywhere on the site.Source: Joi and Blokes' terms.

S6PASSThe contact page prints a street address with a unit number on University Boulevard in Denver, Colorado, headed mailing address.Source: Joi and Blokes' contact page.

S7PASSThe about page prints 399 dollars and 199 dollars per month with no account required.Source: Joi and Blokes' about page.

S8PASSFDA warning letter 728283, June 2026, names Joi and Blokes at the Denver address this site prints, and cites claims that its compounded product is the same bioidentical compound as an approved brand. No FDA action has halted the business, and the seller still trades.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded GLP-1 treatments, compounded GLP-1 and GIP treatments, hormone therapy, peptide therapy.

Enforcement documents on file: 1 warning letter

FDA warning letter 728283, issued June 2026, to Joi and Blokes dba Joi + BlokesClaims on Joi and Blokes' website asserting equivalence between its compounded semaglutide and Ozempic and Wegovy are false or misleading.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Visit Joi and Blokes

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.